Hologic, Inc. logo
Hologic, Inc. (HOLX)
Compare

Hologic, Inc. (HOLX) Free Cash Flow (FCF): $999.60M

The free cash flow (FCF) for Hologic, Inc. (HOLX) is $999.60M. It is below its 12-month average by 3.19% ($1.03B).

HOLX Free Cash Flow (FCF) Chart

HOLX Free Cash Flow (FCF)
$920.10M-19.64% 1Y
Zoom

HOLX Average Free Cash Flow (FCF) Chart

HOLX Current vs Average Free Cash Flow (FCF) Chart

HOLX Free Cash Flow (FCF) Metrics

FREE CASH FLOW (FCF)

$999.60M

FREE CASH FLOW (FCF) AVG TTM

$1.03B

FREE CASH FLOW (FCF) AVG 3Y

$1.24B

FREE CASH FLOW (FCF) AVG 5Y

$1.31B

FREE CASH FLOW (FCF) AVG 10Y

$936.98M

FREE CASH FLOW (FCF) AVG 15Y

$763.87M

FREE CASH FLOW (FCF) AVG 20Y

$627.21M

CURRENT VS TTM AVG

-3.19%

CURRENT VS 3Y AVG

-19.46%

CURRENT VS 5Y AVG

-23.67%

CURRENT VS 10Y AVG

+6.68%

CURRENT VS 15Y AVG

+30.86%

CURRENT VS 20Y AVG

+59.37%

FCF Analysis

Free Cash Flow (TTM)

$999.60M

FCF Yield

5.82%

Price/FCF

17.2

Formula: FCF = Operating Cash Flow - Capital Expenditures

Why FCF matters:

  • Shows actual cash available (not accounting earnings)
  • Funds dividends, buybacks, and debt reduction
  • Less susceptible to accounting manipulation than net income
  • Key metric for DCF valuation models

Hologic, Inc. Free Cash Flow (FCF) Formula & Definition

Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Hologic, Inc. Free Cash Flow (FCF) FAQ

What is the free cash flow (FCF) for Hologic, Inc. (HOLX)?
The free cash flow (FCF) for HOLX stock is $999.60M.
What is the TTM average free cash flow (FCF) for Hologic, Inc. (HOLX)?
The TTM average free cash flow (FCF) for HOLX stock is $1.03B.
What is the 3Y average free cash flow (FCF) for Hologic, Inc. (HOLX)?
The 3Y average free cash flow (FCF) for HOLX stock is $1.24B.
What is the 5Y average free cash flow (FCF) for Hologic, Inc. (HOLX)?
The 5Y average free cash flow (FCF) for HOLX stock is $1.31B.
What is the 10Y average free cash flow (FCF) for Hologic, Inc. (HOLX)?
The 10Y average free cash flow (FCF) for HOLX stock is $936.98M.
What is the 15Y average free cash flow (FCF) for Hologic, Inc. (HOLX)?
The 15Y average free cash flow (FCF) for HOLX stock is $763.87M.
What is the 20Y average free cash flow (FCF) for Hologic, Inc. (HOLX)?
The 20Y average free cash flow (FCF) for HOLX stock is $627.21M.

Hologic, Inc. Free Cash Flow (FCF) History

DATEFREE CASH FLOW (FCF)
2025-09-27$920.10M
2024-09-30$1.15B
2023-09-30$901.00M
2022-09-30$2.00B
2021-09-30$2.15B
2020-09-30$740.20M
2019-09-30$535.90M
2018-09-30$627.30M
2017-09-30$-99.30M
2016-09-30$688.70M
2015-09-30$696.70M
2014-09-30$428.20M
2013-09-30$403.69M
2012-09-30$286.95M
2011-09-30$392.02M
2010-09-30$404.23M
2009-09-30$480.66M
2008-09-30$311.31M
2007-09-30$130.41M
2006-09-30$-9.46M
2005-09-30$36.67M
2004-09-30$18.70M
2003-09-30$-3.42M
2002-09-30$823000.00
2001-09-30$-14.58M
2000-09-30$-6.50M
1999-09-30$-6.60M
1998-09-30$-8.00M
1997-09-30$10.50M
1996-09-30$-1.30M

About Hologic, Inc.

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA
7,063 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini